Graham Capital Management, L.P. Fulgent Genetics, Inc. Transaction History

Graham Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$29.39 - $36.27 $1.25 Million - $1.54 Million	-42,375 Reduced 48.87%	44,328 $1.38 Million
Q4 2022 Feb 14, 2023	BUY	$29.23 - $40.28 $2.53 Million - $3.49 Million	86,703 New	86,703 $2.58 Million
Q2 2022 Aug 15, 2022	SELL	$47.98 - $62.75 $226,513 - $296,242	-4,721 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$49.85 - $96.11 $235,341 - $453,735	4,721 New	4,721 $294,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Graham Capital Management, L.P. with notifications on news.